Filing Details
- Accession Number:
- 0001131096-16-000383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-07 17:46:52
- Reporting Period:
- 2016-09-03
- Filing Date:
- 2016-09-07
- Accepted Time:
- 2016-09-07 17:46:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131096 | Athenahealth Inc | ATHN | Services-Business Services, Nec (7389) | 043387530 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1544395 | Karl Stubelis | C/O Athenahealth, Inc. 311 Arsenal Street Watertown MA 02472 | Vp And Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-09-03 | 1,375 | $0.00 | 1,375 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-09-03 | 447 | $123.61 | 928 | No | 4 | F | Direct | |
Common Stock | Disposition | 2016-09-07 | 928 | $123.36 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2016-09-03 | 1,375 | $0.00 | 1,375 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,375 | 2017-09-03 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit ("RSU") converts into common stock on a one-for-one basis.
- Shares withheld to satisfy tax withholding obligations incurred upon the vesting of RSUs. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on February 25, 2016, in accordance with Rule 10b5-1.
- Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- On November 1, 2013, the Reporting Person was granted 5,500 RSUs. The restricted stock units vest in four equal annual installments beginning on September 3, 2014.